XVIVO PERFUSION AB XVIVO PERFUS (0RKL.L) Financials
0RKL.L Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 2.2 billion | 309.0 million |
2023-06-30 | 1.8 billion | 285.1 million |
2023-03-31 | 1.7 billion | 293.0 million |
0RKL.L Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | ? | ? |
2023-09-30 | 18.3 million | ? |
2023-06-30 | 8.8 million | ? |
2023-03-31 | -22.7 million | ? |
0RKL.L Net Income
Graph available only for supporters. Become a supporter to see it.
Date | Net Income |
---|---|
2023-12-31 | 68.5 million |
2023-09-30 | 2.3 million |
2023-06-30 | 6.9 million |
2023-03-31 | 14.2 million |
0RKL.L Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | - | - | - |
2023-09-30 | 594.3 million | - | - |
2023-06-30 | 171.4 million | - | - |
2023-03-31 | 198.0 million | - | - |
0RKL.L Shares Outstanding
0RKL.L Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | - | - | - |
2023-09-30 | 6.5 million | 27.1 million | 11.8 million | 58.9 million |
2023-06-30 | 6.9 million | 31.6 million | 27.3 million | 41.2 million |
2023-03-31 | 10.3 million | 26.2 million | 19.0 million | 48.4 million |
0RKL.L Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | - |
2023-09-30 | 146.6 million | 39.0 million |
2023-06-30 | 154.6 million | 39.1 million |
2023-03-31 | 140.6 million | 35.8 million |
0RKL.L
Price: SEK403
52 week price:
Earnings Per Share: 0.24 SEK
P/E Ratio: 1168.70
Exchange: LSE
Sector: Healthcare
Industry: Health Care Equipment & Services
Market Capitalization: 102.7 million